Table 1

Clinical data and pathological findings of 14 patients with breast carcinomas (patients 1–14) and 5 with benign breast lesions (patients 15–19)

Patient no.Age (yr)HistologyPathological stageNuclear gradeSize (cm)ERa (fmol/mg)bPgR (fmol/mg)
169LobularT2N0M023.52176
277DuctalT2N0M032.536312
373DuctalT2N1M03Multifocal126
459LobularT1N0M0ND25660
583LobularT2N0M022.533487
680DuctalT2N1M023.51495
782DuctalT2NXM0c2422581
869DuctalT1N1M022453137
955DuctalT2N1M03512715
1072LobularT2N0M022.548270
1171DuctalT1N0M022111
1268Ductal-LobularT1N0M02228368
1348DuctalT1N1M021.76741
1439DuctalT2N0M032.723
1520Fibroadenoma
1664Fibrocystic disease
1745Fibrocystic disease
1847Fibroadenoma
1937Fibroadenoma
  • a ER, estrogen receptor; PgR, progesterone receptor; ND, not determined.

  • b fmol/mg of protein in cytosol.

  • c Axillary node dissection not performed.